Vimarsana
Biggest News Aggregation in the World

Page 41 - Entrypoint Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Entrypoint Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Entrypoint Capital Today - Breaking & Trending Today

Stephens Begins Coverage on Nurix Therapeutics (NASDAQ:NRIX) - Vimarsana News

Stephens Begins Coverage on Nurix Therapeutics (NASDAQ:NRIX)

Stephens initiated coverage on shares of Nurix Therapeutics (NASDAQ:NRIX – Free Report) in a research note published on Tuesday morning, MarketBeat.com reports. The brokerage issued an overweight rating and a $20.00 price target on the stock. NRIX has been the subject of several other research reports. Morgan Stanley lifted their price objective on shares of […]

Source: wkrb13.com
Pliant Therapeutics (NASDAQ:PLRX) Receives Buy Rating from HC Wainwright - Vimarsana News

Pliant Therapeutics (NASDAQ:PLRX) Receives Buy Rating from HC Wainwright

HC Wainwright restated their buy rating on shares of Pliant Therapeutics (NASDAQ:PLRX – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. The firm currently has a $36.00 target price on the stock. A number of other equities analysts also recently weighed in on the stock. Oppenheimer boosted their price […]

Farmers National Banc Corp. (NASDAQ:FMNB) Sees Large Decline in Short Interest - Vimarsana News

Farmers National Banc Corp. (NASDAQ:FMNB) Sees Large Decline in Short Interest

Farmers National Banc Corp. (NASDAQ:FMNB – Get Free Report) was the target of a significant decrease in short interest during the month of April. As of April 30th, there was short interest totalling 526,400 shares, a decrease of 7.1% from the April 15th total of 566,900 shares. Based on an average daily trading volume, of […]

Nurix Therapeutics (NASDAQ:NRIX) Stock Rating Reaffirmed by Stifel Nicolaus - Vimarsana News

Nurix Therapeutics (NASDAQ:NRIX) Stock Rating Reaffirmed by Stifel Nicolaus

Stifel Nicolaus reissued their buy rating on shares of Nurix Therapeutics (NASDAQ:NRIX – Free Report) in a research report released on Wednesday morning, Benzinga reports. The firm currently has a $27.00 target price on the stock. A number of other research analysts have also recently issued reports on the company. Morgan Stanley raised their price […]

Jack in the Box (NASDAQ:JACK) PT Lowered to $112.00 at Loop Capital - Vimarsana News

Jack in the Box (NASDAQ:JACK) PT Lowered to $112.00 at Loop Capital

Jack in the Box (NASDAQ:JACK – Free Report) had its price target cut by Loop Capital from $118.00 to $112.00 in a research note published on Wednesday morning, Benzinga reports. They currently have a buy rating on the restaurant operator’s stock. Other equities analysts have also recently issued reports about the company. Robert W. Baird […]